RNS Number : 2811S
Puma AIM VCT PLC
23 July 2025
Puma AIM VCT plc (the "Company")
Portfolio Update
The Company is pleased to announce that it has invested £0.79m in Verici DX Plc's recent funding round.
Verici DX Plc is a developer of advanced clinical diagnostics focused on kidney transplant patient care.
For further information please contact:
Amy Coburn
Puma AIM VCT plc
020 7408 4050
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.